BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28575221)

  • 1. Sudden cardiac death and Ethical issues of CRISPR technology.
    Vetter N
    Br Med Bull; 2017 Jun; 122(1):1-3. PubMed ID: 28575221
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR: express delivery to any DNA address.
    Peterson A
    Oral Dis; 2017 Jan; 23(1):5-11. PubMed ID: 27040868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmia Management in the Elderly-Implanted Cardioverter Defibrillators and Prevention of Sudden Death.
    Manian U; Gula LJ
    Can J Cardiol; 2016 Sep; 32(9):1117-23. PubMed ID: 27568872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does uncontrolled cardiac death for organ donation raise ethical questions? An opinion survey.
    Goudet V; Albouy-Llaty M; Migeot V; Pain B; Dayhot-Fizelier C; Pinsard M; Gil R; Beloucif S; Robert R
    Acta Anaesthesiol Scand; 2013 Nov; 57(10):1230-6. PubMed ID: 24028284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.
    Charytan DM; Foley R; McCullough PA; Rogers JD; Zimetbaum P; Herzog CA; Tumlin JA;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):721-34. PubMed ID: 26763255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Cappato R; Ali H
    Int J Cardiol; 2017 Jun; 237():38-41. PubMed ID: 28377192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR as a driving force: the Model T of biotechnology.
    Mariscal C; Petropanagos A
    Monash Bioeth Rev; 2016 Jun; 34(2):101-116. PubMed ID: 27619650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-mortem genetic analysis in juvenile cases of sudden cardiac death.
    Campuzano O; Sanchez-Molero O; Allegue C; Coll M; Mademont-Soler I; Selga E; Ferrer-Costa C; Mates J; Iglesias A; Sarquella-Brugada G; Cesar S; Brugada J; Castellà J; Medallo J; Brugada R
    Forensic Sci Int; 2014 Dec; 245():30-7. PubMed ID: 25447171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden Death in Patients With Cardiac Implantable Electronic Devices.
    Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E
    JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Application of CRISPR/Cas Technology to Efficiently Model Complex Cancer Genomes in Stem Cells.
    Albitar A; Rohani B; Will B; Yan A; Gallicano GI
    J Cell Biochem; 2018 Jan; 119(1):134-140. PubMed ID: 28594094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiologic aspects of sudden cardiac death in ischemic heart disease].
    Dukát A
    Bratisl Lek Listy; 1997; 98(7-8):360-7. PubMed ID: 9471328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome-editing debate.
    Camporesi S; Cavaliere G
    Per Med; 2016 Nov; 13(6):575-586. PubMed ID: 28757883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden Arrhythmic Death During Exercise: A Post-Mortem Genetic Analysis.
    Campuzano O; Sanchez-Molero O; Fernandez A; Mademont-Soler I; Coll M; Perez-Serra A; Mates J; Del Olmo B; Pico F; Nogue-Navarro L; Sarquella-Brugada G; Iglesias A; Cesar S; Carro E; Borondo JC; Brugada J; Castellà J; Medallo J; Brugada R
    Sports Med; 2017 Oct; 47(10):2101-2115. PubMed ID: 28255936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology.
    Corrado D; Pelliccia A; Bjørnstad HH; Vanhees L; Biffi A; Borjesson M; Panhuyzen-Goedkoop N; Deligiannis A; Solberg E; Dugmore D; Mellwig KP; Assanelli D; Delise P; van-Buuren F; Anastasakis A; Heidbuchel H; Hoffmann E; Fagard R; Priori SG; Basso C; Arbustini E; Blomstrom-Lundqvist C; McKenna WJ; Thiene G;
    Eur Heart J; 2005 Mar; 26(5):516-24. PubMed ID: 15689345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.